Diagnostic thresholds for free light chains in multiple myeloma depend on the assay used.
Bossuyt X et al.Leukemia. 2017 Nov 20. doi: 10.1038/leu.2017.335. [Epub ahead of print].

Determining therapeutic susceptibility in multiple myeloma by single-cell mass accumulation.
Cetin AE et al. Nat Commun. 2017 Nov 20;8(1):1613. doi: 10.1038/s41467-017-01593-2.

Bone marrow Dikkopf-1 levels are a new independent risk factor for progression in patients with smouldering myeloma.
Dalla Palma B et al. Br J Haematol. 2017 Nov 16. doi: 10.1111/bjh.15026. [Epub ahead of print].

Elevated pre-transplant C-reactive protein identifies a high-risk subgroup in multiple myeloma patients undergoing delayed autologous stem cell transplantation.
Chakraborty R et al. Bone Marrow Transplant. 2017 Nov 13. doi: 10.1038/bmt.2017.228. [Epub ahead of print].

A prospective study comparing whole-body skeletal X-ray survey with 18F-FDG-PET/CT, 18F-NaF-PET/CT and whole-body MRI in the detection of bone lesions in multiple myeloma patients.
Dyrberg E et al. Acta Radiol Open. 2017 Oct 27;6(10):2058460117738809. doi: 10.1177/2058460117738809. eCollection 2017 Oct.

Drug response prediction in high-risk multiple myeloma.
Vangsted AJ et al. Gene. 2017 Nov 6. pii: S0378-1119(17)30917-4. doi: 10.1016/j.gene.2017.10.071. [Epub ahead of print].

Constitutional mutation in CDKN2A is associated with long term survivorship in multiple myeloma: a case report.
Shah V et al. BMC Cancer. 2017 Nov 6;17(1):718. doi: 10.1186/s12885-017-3715-5.

Role of BMI and age in predicting pathologic vertebral fractures in newly diagnosed multiple myeloma patients: A retrospective cohort study.
Chen YL et al. Hematol Oncol. 2017 Nov 6. doi: 10.1002/hon.2486. [Epub ahead of print].

Enumeration and characterization of circulating multiple myeloma cells in patients with plasma cell disorders.
Foulk B et al. Br J Haematol. 2017 Nov 5. doi: 10.1111/bjh.15003. [Epub ahead of print].

Prognostic value of antigen expression in multiple myeloma: A PETHEMA/GEM study on 1,265 patients enrolled in four consecutive clinical trials.
Arana P et al. Leukemia. 2017 Nov 3. doi: 10.1038/leu.2017.320. [Epub ahead of print].